Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Report 2017

Publisher Name :
Date: 04-Dec-2017
No. of pages: 103
Inquire Before Buying

In this report, the global Granulocyte Macrophage Colony Stimulating Factor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Granulocyte Macrophage Colony Stimulating Factor for these regions, from 2012 to 2022 (forecast), covering

- United States

- China

- Europe

- Japan

- Southeast Asia

- India

Global Granulocyte Macrophage Colony Stimulating Factor market competition by top manufacturers/players, with Granulocyte Macrophage Colony Stimulating Factor sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

- Aduro BioTech Inc

- Amgen Inc

- BriaCell Therapeutics Corp

- Cold Genesys Inc

- GlaxoSmithKline Plc

- Humanigen Inc

- Mologen AG

- Morphotek Inc

- Sillajen Biotherapeutics

- Takeda Pharmaceutical Co Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- CG-0070

- Gimsilumab

- GSK-3196165

- Lenzilumab

- MGN-1601

- Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Solid Tumor

- Lymphoma

- Kidney Cancer

- Lung Disease

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Report 2017

Table of Contents
Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Report 2017
1 Granulocyte Macrophage Colony Stimulating Factor Market Overview
1.1 Product Overview and Scope of Granulocyte Macrophage Colony Stimulating Factor
1.2 Classification of Granulocyte Macrophage Colony Stimulating Factor by Product Category
1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 CG-0070
1.2.4 Gimsilumab
1.2.5 GSK-3196165
1.2.6 Lenzilumab
1.2.7 MGN-1601
1.2.8 Others
1.3 Global Granulocyte Macrophage Colony Stimulating Factor Market by Application/End Users
1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Solid Tumor
1.3.3 Lymphoma
1.3.4 Kidney Cancer
1.3.5 Lung Disease
1.3.6 Others
1.4 Global Granulocyte Macrophage Colony Stimulating Factor Market by Region
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2012-2022)
1.4.3 China Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2012-2022)
1.4.4 Europe Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2012-2022)
1.4.5 Japan Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2012-2022)
1.4.6 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2012-2022)
1.4.7 India Granulocyte Macrophage Colony Stimulating Factor Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Granulocyte Macrophage Colony Stimulating Factor (2012-2022)
1.5.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2022)
1.5.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2022)
2 Global Granulocyte Macrophage Colony Stimulating Factor Competition by Players/Suppliers, Type and Application
2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Competition by Players/Suppliers
2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Granulocyte Macrophage Colony Stimulating Factor (Volume and Value) by Type
2.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Type (2012-2017)
2.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Type (2012-2017)
2.3 Global Granulocyte Macrophage Colony Stimulating Factor (Volume and Value) by Region
2.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Region (2012-2017)
2.3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Region (2012-2017)
2.4 Global Granulocyte Macrophage Colony Stimulating Factor (Volume) by Application
3 United States Granulocyte Macrophage Colony Stimulating Factor (Volume, Value and Sales Price)
3.1 United States Granulocyte Macrophage Colony Stimulating Factor Sales and Value (2012-2017)
3.1.1 United States Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
3.1.2 United States Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
3.1.3 United States Granulocyte Macrophage Colony Stimulating Factor Sales Price Trend (2012-2017)
3.2 United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Players
3.3 United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Type
3.4 United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Application
4 China Granulocyte Macrophage Colony Stimulating Factor (Volume, Value and Sales Price)
4.1 China Granulocyte Macrophage Colony Stimulating Factor Sales and Value (2012-2017)
4.1.1 China Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
4.1.2 China Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
4.1.3 China Granulocyte Macrophage Colony Stimulating Factor Sales Price Trend (2012-2017)
4.2 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Players
4.3 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Type
4.4 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Application
5 Europe Granulocyte Macrophage Colony Stimulating Factor (Volume, Value and Sales Price)
5.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales and Value (2012-2017)
5.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
5.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
5.1.3 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Price Trend (2012-2017)
5.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Players
5.3 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Type
5.4 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Application
6 Japan Granulocyte Macrophage Colony Stimulating Factor (Volume, Value and Sales Price)
6.1 Japan Granulocyte Macrophage Colony Stimulating Factor Sales and Value (2012-2017)
6.1.1 Japan Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
6.1.2 Japan Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
6.1.3 Japan Granulocyte Macrophage Colony Stimulating Factor Sales Price Trend (2012-2017)
6.2 Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Players
6.3 Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Type
6.4 Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Application
7 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor (Volume, Value and Sales Price)
7.1 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales and Value (2012-2017)
7.1.1 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Price Trend (2012-2017)
7.2 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Players
7.3 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Type
7.4 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Application
8 India Granulocyte Macrophage Colony Stimulating Factor (Volume, Value and Sales Price)
8.1 India Granulocyte Macrophage Colony Stimulating Factor Sales and Value (2012-2017)
8.1.1 India Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
8.1.2 India Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
8.1.3 India Granulocyte Macrophage Colony Stimulating Factor Sales Price Trend (2012-2017)
8.2 India Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Players
8.3 India Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Type
8.4 India Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share by Application
9 Global Granulocyte Macrophage Colony Stimulating Factor Players/Suppliers Profiles and Sales Data
9.1 Aduro BioTech Inc
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Granulocyte Macrophage Colony Stimulating Factor Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Amgen Inc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Granulocyte Macrophage Colony Stimulating Factor Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 BriaCell Therapeutics Corp
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Granulocyte Macrophage Colony Stimulating Factor Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Cold Genesys Inc
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Granulocyte Macrophage Colony Stimulating Factor Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 GlaxoSmithKline Plc
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Granulocyte Macrophage Colony Stimulating Factor Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Humanigen Inc
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Granulocyte Macrophage Colony Stimulating Factor Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Mologen AG
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Granulocyte Macrophage Colony Stimulating Factor Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Morphotek Inc
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Granulocyte Macrophage Colony Stimulating Factor Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Sillajen Biotherapeutics
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Granulocyte Macrophage Colony Stimulating Factor Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Takeda Pharmaceutical Co Ltd
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Granulocyte Macrophage Colony Stimulating Factor Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
10 Granulocyte Macrophage Colony Stimulating Factor Maufacturing Cost Analysis
10.1 Granulocyte Macrophage Colony Stimulating Factor Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
10.3 Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Granulocyte Macrophage Colony Stimulating Factor Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Granulocyte Macrophage Colony Stimulating Factor Major Manufacturers in 2016
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2017-2022)
14.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Granulocyte Macrophage Colony Stimulating Factor Price and Trend Forecast (2017-2022)
14.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2017-2022)
14.3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Type (2017-2022)
14.3.3 Global Granulocyte Macrophage Colony Stimulating Factor Price Forecast by Type (2017-2022)
14.4 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Granulocyte Macrophage Colony Stimulating Factor
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type (Product Category) in 2016
Figure CG-0070 Product Picture
Figure Gimsilumab Product Picture
Figure GSK-3196165 Product Picture
Figure Lenzilumab Product Picture
Figure MGN-1601 Product Picture
Figure Others Product Picture
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Application in 2016
Figure Solid Tumor Examples
Table Key Downstream Customer in Solid Tumor
Figure Lymphoma Examples
Table Key Downstream Customer in Lymphoma
Figure Kidney Cancer Examples
Table Key Downstream Customer in Kidney Cancer
Figure Lung Disease Examples
Table Key Downstream Customer in Lung Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size (Million USD) by Regions (2012-2022)
Figure United States Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Granulocyte Macrophage Colony Stimulating Factor Sales Share by Players/Suppliers
Figure 2017 Granulocyte Macrophage Colony Stimulating Factor Sales Share by Players/Suppliers
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Players
Table 2017 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Players
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type (2012-2017)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate by Type (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type (2012-2017)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate by Type (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Region (2012-2017)
Figure Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Region (2012-2017)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate by Region in 2016
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor by Region (2012-2017)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate by Region in 2016
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor by Region (2012-2017)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region in 2016
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Application (2012-2017)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2012-2017)
Figure United States Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Granulocyte Macrophage Colony Stimulating Factor Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Players (2012-2017)
Table United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players (2012-2017)
Figure United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players in 2016
Table United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Type (2012-2017)
Table United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type (2012-2017)
Figure United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type in 2016
Table United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Application (2012-2017)
Table United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application (2012-2017)
Figure United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application in 2016
Figure China Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Price (USD/Pcs) Trend (2012-2017)
Table China Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Players (2012-2017)
Table China Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players (2012-2017)
Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players in 2016
Table China Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Type (2012-2017)
Table China Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type (2012-2017)
Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type in 2016
Table China Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Application (2012-2017)
Table China Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application (2012-2017)
Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application in 2016
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players in 2016
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type in 2016
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application in 2016
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players (2012-2017)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players in 2016
Table Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type (2012-2017)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type in 2016
Table Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application (2012-2017)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application in 2016
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players in 2016
Table Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type in 2016
Table Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application in 2016
Figure India Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Granulocyte Macrophage Colony Stimulating Factor Sales Price (USD/Pcs) Trend (2012-2017)
Table India Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Players (2012-2017)
Table India Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players (2012-2017)
Figure India Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Players in 2016
Table India Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Type (2012-2017)
Table India Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type (2012-2017)
Figure India Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type in 2016
Table India Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Application (2012-2017)
Table India Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application (2012-2017)
Figure India Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Application in 2016
Table Aduro BioTech Inc Basic Information List
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2012-2017)
Figure Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales Global Market Share (2012-2017
Figure Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Global Market Share (2012-2017)
Table Amgen Inc Basic Information List
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2012-2017)
Figure Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales Global Market Share (2012-2017
Figure Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Global Market Share (2012-2017)
Table BriaCell Therapeutics Corp Basic Information List
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2012-2017)
Figure BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales Global Market Share (2012-2017
Figure BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Revenue Global Market Share (2012-2017)
Table Cold Genesys Inc Basic Information List
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2012-2017)
Figure Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales Global Market Share (2012-2017
Figure Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Revenue Global Market Share (2012-2017)
Table Humanigen Inc Basic Information List
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Humanigen Inc Granulocyte Macrophage Colony Stimul
  • Global Human Growth Hormone (hGH) Market Research Report 2017
    Published: 14-Dec-2017        Price: US 2900 Onwards        Pages: 100
    In this report, the global Human Growth Hormone (hGH) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Growth Hormone (hGH) in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global Acromegaly Treatment Market Size, Status and Forecast 2022
    Published: 14-Dec-2017        Price: US 3300 Onwards        Pages: 99
    This report studies the global Acromegaly Treatment market, analyzes and researches the Acromegaly Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Pfizer Inc - Chiasma Inc - Novartis AG - Ipsen Biopharmaceuticals Inc - Wockhardt Ltd - Troikaa Pharmaceuticals Limited - VHB Life Sciences Limited - GlaxoSmithKline plc ......
  • Global Acyl CoA Desaturase Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the global Acyl CoA Desaturase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Acyl CoA Desaturase for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japa......
  • Global Enteric Softgel Capsules Market Research Report 2017
    Published: 14-Dec-2017        Price: US 2900 Onwards        Pages: 106
    In this report, the global Enteric Softgel Capsules market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Enteric Softgel Capsules in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - ......
  • Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017
    Published: 14-Dec-2017        Price: US 3500 Onwards        Pages: 116
    This report studies Non-Insulin Therapies for Diabetes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - GSK - Eli Lilly - Sumitomo Dainippon Pharma - Int......
  • Global Combination Vaccine Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the global Combination Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Combination Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japa......
  • Global Axial Spondyloarthritis Drugs Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Axial Spondyloarthritis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Axial Spondyloarthritis Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - ......
  • Global Dermatomyositis Drug Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 116
    In this report, the global Dermatomyositis Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Dermatomyositis Drug for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Ja......
  • Global Erythropoietin Drugs Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the global Erythropoietin Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K ML), revenue (Million USD), market share and growth rate of Erythropoietin Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Jap......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs